Personal profile
-
Safety and Efficacy of PrimeC in Amyotrophic Lateral Sclerosis: The PARADIGM Randomized Clinical Trial
Cudkowicz, M., Drory, V. E., Chio, A., Lunetta, C., Shoesmith, C., Van Eijk, R. P. A., Salomon-Zimri, S., Shtossel, D., Kerem, N., Shapira, G., Shomron, N., Russek-Blum, N., Tracik, F., Rosenfeld, J. & Shefner, J., 2026, (Accepted/In press) In: JAMA Neurology.Research output: Contribution to journal › Article › peer-review
Open Access -
Amyotrophic Lateral Sclerosis
Rosenfeld, J. & Edwards, M., Jan 1 2025, Encyclopedia of the Neurological Sciences. Elsevier, p. V4:1-V4:12Research output: Chapter in Book/Report/Conference proceeding › Chapter
-
An ALS assembly modulator signature in peripheral blood mononuclear cells: implications for ALS pathophysiology, therapeutics, and diagnostics
Yu, S. F., Michon, M., Lingappa, A. F., Paulvannan, K., Solas, D., Staats, K., Ichida, J., Dey, D., Rosenfeld, J. & Lingappa, V. R., Apr 28 2025, In: Clinical Proteomics. 22, 1, 16.Research output: Contribution to journal › Article › peer-review
Open Access -
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial
Authors/Writing Committee for the HEALEY ALS Platform Trial:, Apr 1 2025, In: JAMA. 333, 13, p. 1138-1149 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial
HEALEY ALS Platform Trial Study Group, 2025, In: JAMA Network Open. 8, 2, e2459058.Research output: Contribution to journal › Article › peer-review
Open Access